Advanced Therapies USA 2026

November 4-5, 2026
Boston, Massachusetts

The Advanced Therapies USA Congress, taking place November 4-5, 2026, in Boston, brings together leaders across the cell and gene therapy ecosystem for two days of discussion on the technologies, strategies, and development models shaping the future of advanced therapies. With participation from biotech, pharma, startups, researchers, clinicians, regulators, and payers, the meeting spans the full value chain from preclinical and clinical development through manufacturing, regulatory planning, market access, and commercialization.

For clinical-stage advanced therapy developers, the 2026 program highlights many of the issues that directly affect development planning and execution, including clinical trial design, regulatory strategy, evidence generation, supply chain logistics, and scaling toward broader patient access. These topics reflect the increasing importance of experienced clinical execution in complex programs, where logistics, site coordination, and operational oversight are as critical as the underlying science.

PRC Clinical supports sponsors developing advanced therapies with hands-on clinical trial management and execution-focused support designed to maintain quality, timelines, and momentum across specialized programs.

For up-to-date conference information, please visit the conference website linked below. To connect with the PRC Clinical team, fill out the form below.

View the Conference Website